Drug for depressing serum got and gpt activities and hepatic disease curative composition

摘要

A drug containing an effective dose of calcitonin for depressing the elevated activities of serum glutamic-oxaloacetic transaminase and glutamic-pyruvic transaminase, both being hepatic leaking enzymes, and a novel hepatic disease curative composition containing calcitonin as the active ingredient and having extremely reduced side effects. The above drug containing calcitonin can effectively depress the elevated activities of the leaking enzymes serving as an index of hepatic injury in hepatic diseases. Therefore, a drug composition containing calcitonin as the active ingredient in a dose effective against hepatic diseases can be utilized for treating various hepatic diseases such as drug-induced hepatitis, alcoholic hepatitis and autoimmune hepatitis.